COVID-19 vaccine

Latest

COVID-19 vaccine

Featured Neuroscience Open Neuroscience Articles

·April 7, 2020

Successful MERS vaccine in mice may hold promise for COVID-19 vaccine

Researchers have developed a new vaccine that fully protects mice against MERS by using a harmless virus to deliver MERS-CoV into cells and generate an immune response. The vaccine is an innocuous parainfluenza virus (PIV5) which carries the spike protein MERS uses to infect cells. Findings show the PIV5 based vaccine could be a useful platform for COVID-19. Read More

Featured Neuroscience Neuroscience Videos Open Neuroscience Articles

·April 2, 2020

COVID-19 vaccine candidate shows promise in first peer-reviewed research

A new COVID-19 vaccine produces antibodies specific to SARS-CoV-2 at quantities believed sufficient for neutralizing the virus, a mouse model study reveals. The new vaccine using an innovative microneedle array on fingertip-sized pads, which increases the vaccine potency. Read More

Featured Neuroscience

·March 28, 2020

On-again, off-again social distancing might prevent overwhelming hospitals while building immunity to COVID-19

Intermittent social distancing may have to be employed to reduce the burden on the health care system as a result of COVID-19. If COVID-19 is a seasonal ailment, like the flu, a new model shows physical distancing occurring between 25 and 75% of the time would help build up herd immunity and prevent health system overload. Read More

Featured Neuroscience

·March 23, 2020

Tuberculosis BCG-based vaccine may be effective against COVID-19

VPM1002, a vaccine candidate based on the tuberculosis BCG vaccine, may be effective in protecting against COVID-19. Previous studies in mice have shown the BCG vaccine is effective at protecting against several respiratory viral infections. If effective against coronavirus, researchers hope the vaccine can bridge the time gap until a specific SARS-CoV-2 vaccine is available. Read More

Featured Neuroscience

·March 21, 2020

New vaccine candidate for COVID-19 identified

Researchers report they have identified a vaccine candidate for COVID-19 and are working towards phase one clinical testing. A chimpanzee adenovirus vaccine vector was chosen as the most suitable vaccine technology for SARS-CoV-2 as it can generate a stronger immune response in one dose and is not a replicating virus. Read More

Featured Neuroscience

·March 16, 2020

Designing a coronavirus vaccine: Researchers prepare for next year and beyond

Researchers are making progress in developing potential vaccines for coronavirus infections. While a vaccine for COVID-19 might be over a year away from market, researchers are looking ahead to attempt to prevent future outbreaks. Read More

This shows a man in an empty parking lot

Featured Neuroscience

·March 16, 2020

COVID-19 ‘Worry about 4 weeks from now,’ researchers warn

With the peak of COVID-19 cases occurring between 3.5 to four weeks after controlled interventions were put into place in China, US researchers are urging the public to ramp up social distancing efforts and increase testing immediately. Read More

Featured Neuroscience

·March 16, 2020

NIH Clinical Trial of Investigational Vaccine for COVID-19 Begins

A phase 1 trial evaluating an investigational vaccine designed to protect against COVID-19 has begun in Seattle. The study will enroll 45 healthy people aged 18 to 55, over approximately 6 weeks. The first participant received the investigational vaccine today. Adults in the Seattle area may join the study. Read More